可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Binder CJ, Chang MK, Shaw PX, et al. Innate and acquired immunity in atherogenesis[J]. Nat Med, 2002,8(11):1218-1226.
[2] Getz GS. The matic review series:the immune system and atherogenesis. Immune function in atherogenesis[J]. J lipid rese, 2005,46(1):1-10.
[3] Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005,352(16):1685-1695.
[4] Daugherty A, Rateri DL. T lymphocytes in atherosclerosis: the yinyang of Th1 and Th2 influence on lesion formation[J]. Circ Res,2002,90(10):1039 -1040.
[5] Khalloulaschet J, J, Caligiuri G, Groyer E, et al. The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease[J]. Arterioscler Thromb Vasc Biol, 2006,26(2):353 - 358.
[6] Elhage R, Gourdy P, Brouchet L, et al. Deleting TCR alpha beta+ or CD4+T lymphocytes leads to opposite effects on sitespecific atherosclerosis in female apolipoprotein Edeficiency mice[J]. Am J Pathol, 2004,165(6):2013-2018.
[7] Nakajima T, Schulte S, Warrington KJ, et al. Tcellmediated lysis of endothelial cells in acute coronary syndromes[J]. Circulation, 2002,105(5):570-575.
[8] Valgimigli M, Agnoletti L, Curello S, et al. Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells:a possiblelink to pancoronary syndromes[J]. Circulation,2003,107(2):264 -270.
[9] Laurat E, Poirier B, Tupin E, et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein Eknockout mice[J]. Circulation, 2001,104(2):197-202.
[10]Methe H, Brunner S, Wiegand D, et al. Enhanced Thelper1 lymphocyte activation patterns in acute coronary syndromes[J]. J Am coll cardiol,2005,45(12):1939-1945.
[11]Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal Tcell proliferation and plaque instability in acute coronary syndromes[J]. Circulation, 2000,102(25):2883-2888.
[12]Potteaux S, Esposito B, Oostrom O, et al. Leukocytederived interleukin 10 is required for protection against atherosclerosis in lowdensity lipoprotein receptor knockout mice[J]. Arterioscler Thromb Vasc biol,2004,24(8):1474 - 1478.
[13]Soejima H, Irie A, Miyamoto S, et al. Preference toward a Thelper type 1 response in patients with coronary spastic angina[J]. Circulation,2003,107(17):2196-2200.